These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 37802154)

  • 1. Altered calcium signaling in Bergmann glia contributes to spinocerebellar ataxia type-1 in a mouse model of SCA1.
    Nanclares C; Noriega-Prieto JA; Labrada-Moncada FE; Cvetanovic M; Araque A; Kofuji P
    Neurobiol Dis; 2023 Oct; 187():106318. PubMed ID: 37802154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indirect Negative Effect of Mutant Ataxin-1 on Short- and Long-Term Synaptic Plasticity in Mouse Models of Spinocerebellar Ataxia Type 1.
    Shuvaev AN; Belozor OS; Mozhei OI; Shuvaev AN; Fritsler YV; Khilazheva ED; Mosyagina AI; Hirai H; Teschemacher AG; Kasparov S
    Cells; 2022 Jul; 11(14):. PubMed ID: 35883691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of Wnt-β-catenin signaling in Purkinje cells and Bergmann glia in spinocerebellar ataxia type 1.
    Luttik K; Tejwani L; Ju H; Driessen T; Smeets CJLM; Edamakanti CR; Khan A; Yun J; Opal P; Lim J
    Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2208513119. PubMed ID: 35969780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic optogenetic stimulation of Bergman glia leads to dysfunction of EAAT1 and Purkinje cell death, mimicking the events caused by expression of pathogenic ataxin-1.
    Shuvaev AN; Belozor OS; Mozhei O; Yakovleva DA; Potapenko IV; Shuvaev AN; Smolnikova MV; Salmin VV; Salmina AB; Hirai H; Teschemacher AG; Kasparov S
    Neurobiol Dis; 2021 Jul; 154():105340. PubMed ID: 33753288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebellar Heterogeneity and Selective vulnerability in Spinocerebellar Ataxia Type 1 (SCA1).
    Hamel K; Moncada EL; Sheeler C; Rosa JG; Gilliat S; Zhang Y; Cvetanovic M
    Neurobiol Dis; 2024 Jul; 197():106530. PubMed ID: 38750673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinocerebellar ataxia type 7 cerebellar disease requires the coordinated action of mutant ataxin-7 in neurons and glia, and displays non-cell-autonomous bergmann glia degeneration.
    Furrer SA; Mohanachandran MS; Waldherr SM; Chang C; Damian VA; Sopher BL; Garden GA; La Spada AR
    J Neurosci; 2011 Nov; 31(45):16269-78. PubMed ID: 22072678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bergmann glial S100B activates myo-inositol monophosphatase 1 and Co-localizes to purkinje cell vacuoles in SCA1 transgenic mice.
    Vig PJ; Shao Q; Subramony SH; Lopez ME; Safaya E
    Cerebellum; 2009 Sep; 8(3):231-44. PubMed ID: 19593677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Memantine suppresses the excitotoxicity but fails to rescue the ataxic phenotype in SCA1 model mice.
    Belozor OS; Vasilev A; Mileiko AG; Mosina LD; Mikhailov IG; Ox DA; Boitsova EB; Shuvaev AN; Teschemacher AG; Kasparov S; Shuvaev AN
    Biomed Pharmacother; 2024 May; 174():116526. PubMed ID: 38574621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal Atrophy Early in Degenerative Ataxia Is a Compensatory Mechanism to Regulate Membrane Excitability.
    Dell'Orco JM; Wasserman AH; Chopra R; Ingram MA; Hu YS; Singh V; Wulff H; Opal P; Orr HT; Shakkottai VG
    J Neurosci; 2015 Aug; 35(32):11292-307. PubMed ID: 26269637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glial S100B protein modulates mutant ataxin-1 aggregation and toxicity: TRTK12 peptide, a potential candidate for SCA1 therapy.
    Vig PJ; Hearst S; Shao Q; Lopez ME; Murphy HA; Safaya E
    Cerebellum; 2011 Jun; 10(2):254-66. PubMed ID: 21384195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purkinje cell COX deficiency and mtDNA depletion in an animal model of spinocerebellar ataxia type 1.
    Ripolone M; Lucchini V; Ronchi D; Fagiolari G; Bordoni A; Fortunato F; Mondello S; Bonato S; Meregalli M; Torrente Y; Corti S; Comi GP; Moggio M; Sciacco M
    J Neurosci Res; 2018 Sep; 96(9):1576-1585. PubMed ID: 30113722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single nuclei RNA sequencing investigation of the Purkinje cell and glial changes in the cerebellum of transgenic Spinocerebellar ataxia type 1 mice.
    Borgenheimer E; Hamel K; Sheeler C; Moncada FL; Sbrocco K; Zhang Y; Cvetanovic M
    Front Cell Neurosci; 2022; 16():998408. PubMed ID: 36457352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-ataxic loss of intrinsic plasticity and motor learning in a mouse model of SCA1.
    Osório C; White JJ; Lu H; Beekhof GC; Fiocchi FR; Andriessen CA; Dijkhuizen S; Post L; Schonewille M
    Brain; 2023 Jun; 146(6):2332-2345. PubMed ID: 36352508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebellar contribution to cognitive deficits and prefrontal cortex dysfunction in Spinocerebellar Ataxia Type 1 (SCA1).
    Sbrocco K; Borgenheimer E; Zhang Y; Koob M; Cvetanovic M
    bioRxiv; 2024 Jul; ():. PubMed ID: 39026827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress in pathogenesis studies of spinocerebellar ataxia type 1.
    Cummings CJ; Orr HT; Zoghbi HY
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1079-81. PubMed ID: 10434309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive impairment of cerebellar mGluR signalling and its therapeutic potential for cerebellar ataxia in spinocerebellar ataxia type 1 model mice.
    Shuvaev AN; Hosoi N; Sato Y; Yanagihara D; Hirai H
    J Physiol; 2017 Jan; 595(1):141-164. PubMed ID: 27440721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Strategies for Spinocerebellar Ataxia Type 1.
    Kerkhof LMC; van de Warrenburg BPC; van Roon-Mom WMC; Buijsen RAM
    Biomolecules; 2023 May; 13(5):. PubMed ID: 37238658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-symptomatic Delivery of Brain-Derived Neurotrophic Factor (BDNF) Ameliorates Spinocerebellar Ataxia Type 1 (SCA1) Pathogenesis.
    Sheeler C; Rosa JG; Borgenheimer E; Mellesmoen A; Rainwater O; Cvetanovic M
    Cerebellum; 2021 Jun; 20(3):420-429. PubMed ID: 33394333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ataxin-1 regulates the cerebellar bioenergetics proteome through the GSK3β-mTOR pathway which is altered in Spinocerebellar ataxia type 1 (SCA1).
    Sánchez I; Balagué E; Matilla-Dueñas A
    Hum Mol Genet; 2016 Sep; 25(18):4021-4040. PubMed ID: 27466200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SCA7 Mouse Cerebellar Pathology Reveals Preferential Downregulation of Key Purkinje Cell-Identity Genes and Shared Disease Signature with SCA1 and SCA2.
    Niewiadomska-Cimicka A; Doussau F; Perot JB; Roux MJ; Keime C; Hache A; Piguet F; Novati A; Weber C; Yalcin B; Meziane H; Champy MF; Grandgirard E; Karam A; Messaddeq N; Eisenmann A; Brouillet E; Nguyen HHP; Flament J; Isope P; Trottier Y
    J Neurosci; 2021 Jun; 41(22):4910-4936. PubMed ID: 33888607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.